These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
213 related articles for article (PubMed ID: 5937432)
41. [Clinical expeiences with special indications for proscillaridine A in elderly and cirrhotic patients]. Strobbia R; Beggiato O; Manzoni A G Gerontol; 1967 Jul; 15(7):827-64. PubMed ID: 5606219 [No Abstract] [Full Text] [Related]
43. [Contribution to the konwledge of some effects of proscillaridin on the cardiovascular system. Electrocardiographic and radiocardiographic research]. Sorrentino F; Musco A; Cascone O; Modica G Clin Ter; 1966 Jul; 38(1):39-48. PubMed ID: 5990470 [No Abstract] [Full Text] [Related]
44. [Oral heart and circulatory therapy with a new combination glycoside preparation]. Fischer T Ther Ggw; 1966 Feb; 105(2):239-49. PubMed ID: 5915867 [No Abstract] [Full Text] [Related]
45. [On the therapy of heart insufficiency with the pure glycoside Proscillaridin A]. Lampe W; Tergau G Med Welt; 1966 Apr; 18():1034-9. PubMed ID: 5955405 [No Abstract] [Full Text] [Related]
46. [Erychroside treatment of patients with circulatory insufficiency]. Belostochnaia NG Vrach Delo; 1966 Dec; 12():30-4. PubMed ID: 6002712 [No Abstract] [Full Text] [Related]
47. [New aspects of glycoside therapy]. Klepzig H Z Allgemeinmed; 1972 Mar; 48(9):418-21. PubMed ID: 4402437 [No Abstract] [Full Text] [Related]
48. [Directions for treatment of heart disorders and hypertensive states]. Mölleney W Med Monatsschr; 1967 Sep; 21(9):414-7. PubMed ID: 5613644 [No Abstract] [Full Text] [Related]
49. [Experiences with the cardiac glycoside Proscillaridin A (Sandoscill)]. Amirfallah A; Einert HJ Munch Med Wochenschr; 1967 Aug; 109(33):1690-2. PubMed ID: 5631640 [No Abstract] [Full Text] [Related]
50. [Beta-acetyldigoxin and glycoside tolerance--clinical experiences]. Schröer W; Gerhard K Landarzt; 1968 Mar; 44(9):425-34. PubMed ID: 5718780 [No Abstract] [Full Text] [Related]
52. [Influencing the cardiotonic effect of proscillaridin by verapamil]. Manns KJ Med Klin; 1969 Oct; 64(44):2022-7. PubMed ID: 5370836 [No Abstract] [Full Text] [Related]
53. [Sandoscill--the cardiac glycoside for daily practice]. Z Allgemeinmed; 1971 Jul; 47(20):1054-5. PubMed ID: 5106069 [No Abstract] [Full Text] [Related]
54. [Cardiac treatment of out-patients using encordin]. Schütz E Munch Med Wochenschr; 1969 Oct; 111(43):2239-43. PubMed ID: 5395247 [No Abstract] [Full Text] [Related]
55. [Experiences with the clinical use of proscillaridin A]. Milde HW Med Welt; 1969 Mar; 10():531-5. PubMed ID: 5814419 [No Abstract] [Full Text] [Related]
56. [Therapeutic note on the use of talusin and theo-talusin in ambulatory patients]. Wirthner H Praxis; 1969 Oct; 58(42):1350-1. PubMed ID: 5396158 [No Abstract] [Full Text] [Related]
57. [Soluretic effect of proscillaridine. Study on normal subjects and on cardiopathic patients during heart failure]. Forconi S; Puccetti F Minerva Nefrol; 1968; 15(6):392-9. PubMed ID: 5734799 [No Abstract] [Full Text] [Related]
58. [Therapy of the slightly damaged heart with a cardiotonic agent]. Guttmann W Med Welt; 1969 Sep; 37():2035-7. PubMed ID: 5389269 [No Abstract] [Full Text] [Related]